Clinipace appoints Bud Owen and Daryl Porter

pharmafile | February 19, 2010 | Appointment | Research and Development Clinipace, appointment, research and development 

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has joined the company as chief technology officer.

Owen will lead the accounting, treasury, and tax group and be a key member of Clinipace’s mergers and acquisitions team.

He initially joined Clinipace as an advisor during the recent acquisition of Worldwide Clinical Research.

Advertisement

Prior to joining Clinipace, Owen served as chief financial officer at a number of large and small companies in the software, web services, and manufacturing industries, including MediaSpan Group, Reichhold Chemicals, and Tables Surfaces, a company he co-founded.

Meanwhile Porter will lead the service engineering, product engineering, and cloud computing infrastructure teams.

Prior to joining Clinipace Worldwide, Porter spent 18 years at Oracle Corporation and held several executive-level positions in both enterprise product development and enterprise support services.

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …

The Gateway to Local Adoption Series

Latest content